Chembio Diagnostics (NASDAQ: CEMI) has been awarded a grant from the Paul G. Allen Ebola Program to develop a POC ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE